guohua hu

Prof. guohua hu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2022 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
DYDan Yu
Dan Yu
MPMin Pan
Min Pan
YLYanshi Li
Yanshi Li
TLTao Lu
Tao Lu
GHguohua hu
guohua hu
GHGuohua Hu
Guohua Hu
Background: Lymph node metastasis is the main cause of poor prognosis of head and neck squamous carcinoma (HNSCC) patients. N6-methyladenosine (m6A) RNA modification is an emerging epigenetic regulatory mechanism for gene expression, and as a novel m6A reader protein, IGF2BP2 has been implicated in tumor progression and metastasis. However, not much is currently known about the functional roles of IGF2BP2 in HNSCC, and whether IGF2BP2 regulates lymphatic metastasis through m6A modification in HNSCC remains to be determined. Methods: The expression and overall survival (OS) probability of m6A-related regulators in HNSCC were analyzed with The Cancer Genome Atlas (TCGA) dataset and GEPIA website tool, respectively. The expression levels of IGF2BP2 were measured in HNSCC tissues and normal adjacent tissues. To study the effects of IGF2BP2 on HNSCC cell metastasis in vitro and in vivo, gain- and loss- of function methods were employed. RIP, MeRIP, luciferase reporter and mRNA stability assays were performed to explore the epigenetic mechanism of IGF2BP2 in HNSCC. Results: We investigated 20 m6A-related regulators in HNSCC and discovered that only the overexpression of IGF2BP2 was associated with a poor OS probability and an independent prognostic factor for HNSCC patients. Additionally, we demonstrated that IGF2BP2 was overexpressed in HNSCC tissues, and significantly correlated to lymphatic metastasis and poor prognosis. Functional studies have shown that IGF2BP2 promotes both HNSCC cell migration as well as invasion via the epithelial-mesenchymal transition (EMT) process in vitro, and IGF2BP2 knockdown significantly inhibited lymphatic metastasis and lymphangiogenesis in vivo. Mechanistic investigations revealed that Slug, a key EMT-related transcriptional factor, is the direct target of IGF2BP2, and essential for IGF2BP2-regulated EMT and metastasis in HNSCC. Furthermore, we demonstrated that IGF2BP2 recognizes and binds the m6A site in the coding sequence (CDS) region of Slug and promotes its mRNA stability. Conclusions: Collectively, our study uncovers the oncogenic role and potential mechanism of IGF2BP2, which serves as a m6A reader, in controlling lymphatic metastasis and EMT in HNSCC, suggesting that IGF2BP2 may act as a therapeutic target and prognostic biomarker for HNSCC patients with metastasis.

3 May 2023 in Experimental Hematology & Oncology
Verified
Journal Article
Open access
PDF file
MWMin Wang
Min Wang
MPMin Pan
Min Pan
YLYanshi Li
Yanshi Li
TLTao Lu
Tao Lu
GHguohua hu
guohua hu
GHGuohua Hu
Guohua Hu
Background: Head and neck squamous cell carcinoma (HNSCC) is highly aggressive with a significant tropism of lymph nodes, which restricts treatment options and negatively impacts patient outcomes. Although progress has been made in understanding the molecular mechanisms underlying lymphatic metastasis (LM), these mechanisms remain elusive. ANXA6 is a scaffold protein that participates in tumor pathogenesis and autophagy regulation; however, how ANXA6 affects autophagy and LM in HNSCC cells remains unknown. Methods: RNA sequencing was performed on HNSCC clinical specimens with or without metastasis as well as on The Cancer Genome Atlas dataset to investigate ANXA6 expression and survival. Both in vitro and in vivo studies were performed to investigate the role of ANXA6 in the regulation of LM in HNSCC. The molecular mechanism by which ANXA6 interacts with TRPV2 was examined at the molecular level. Results: ANXA6 expression was significantly upregulated in HNSCC patients with LM and higher expression was associated with poor prognosis. ANXA6 overexpression promoted the proliferation and mobility of FaDu and SCC15 cells in vitro; however, ANXA6 knockdown retarded LM in HNSCC in vivo. ANXA6 induced autophagy by inhibiting the AKT/mTOR signaling pathway in HNSCC, thereby regulating the metastatic capability of the disease. Furthermore, ANXA6 expression positively correlated with TRPV2 expression both in vitro and in vivo. Lastly, TRPV2 inhibition reversed ANXA6-induced autophagy and LM. Conclusions: These results indicate that the ANXA6/TRPV2 axis facilitates LM in HNSCC by stimulating autophagy. This study provides a theoretical basis for investigating the ANXA6/TRPV2 axis as a potential target for the treatment of HNSCC, as well as a biomarker for predicting LM.

18 December 2023 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
ZLZhiming Ling
Zhiming Ling
GHguohua hu
guohua hu
GHguohua hu
guohua hu
WMWei Ma
Wei Ma
XWXiaoqiang Wang
Xiaoqiang Wang
QZQuan Zeng
Quan Zeng

6 October 2025 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
JWJiamei Wen
Jiamei Wen
QLQingjia Luo
Qingjia Luo
ZWZi Wang
Zi Wang
HZHai Zhang
Hai Zhang
GHguohua hu
guohua hu
GHguohua hu
guohua hu

28 September 2026 in Acta Oto-Laryngologica Case Reports
Verified
Journal Article
Open access
HZHai Zhang
Hai Zhang
RZRui Zhang
Rui Zhang
GHGuohua Hu
Guohua Hu
GHguohua hu
guohua hu
1. Schwannomas or neurilemmomas are neurogenic tumors that originate from the Schwann cells that make up the myelin sheaths in the peripheral nervous system. Schwannomas are benign and encapsulated...

19 March 2026 in American Journal of Otolaryngology
Verified
Journal Article
Open access
HZHai Zhang
Hai Zhang
WMWei Ma
Wei Ma
XWXiaoqiang Wang
Xiaoqiang Wang
GHGuohua Hu
Guohua Hu
MPMin Pan
Min Pan
GHguohua hu
guohua hu
Lingual thyroglossal duct cysts (LTGDCs) are a rare variant of thyroglossal duct cysts (TGDCs) with significant surgical challenges due to their special anatomical location at the base of the tongue. This retrospective case series aimed to evaluate the feasibility, safety, and efficacy of 30° endoscopic combined with FK retractors-assisted transoral coblation excision of LTGDCs. A retrospective analysis was performed on 6 consecutive patients diagnosed with LTGDCs who underwent the above surgical procedure at the First Affiliated Hospital of Chongqing Medical University from January 2023 to June 2025. The surgical approach involved exposing the tongue base and epiglottis with FK retractors under visualization with a 30° endoscope. The cyst was resected along its margin using plasma coblation down to the level of the hyoid bone, with subsequent ablation of its attachment site. Clinical data, examination findings, surgical parameters, and outcomes were collected and analyzed. All 6 patients successfully underwent endoscopic combined with FK retractors-assisted transoral coblation excision of LTGDCs. The median operation time was 55 min (range, 42-65 min), and the median amount of bleeding was 7.5 ml (range, 3-20 ml). A soft diet was initiated on the first postoperative day for all patients, and the median length of postoperative hospitalization was 4 days (range, 3-6 days). No postoperative complications were observed (Clavien-Dindo grade 0), and no airway compromise or swallowing difficulties occurred. During a median follow-up of 15 months (range, 6-30 months), no clinical or radiologic recurrence was detected, and all preoperative symptoms were significantly improved. 30° endoscopic combined with FK retractors-assisted transoral coblation excision of LTGDCs is feasible and safe for the treatment of LTGDCs in this small case series. Complete resection of the cyst to the hyoid bone level and ablation of the attachment site can achieve good short-term outcomes.